Deutsche Bank Aktiengesellschaft restated their buy rating on shares of Porvair (LON:PRV – Free Report) in a research report sent to investors on Thursday morning,Digital Look reports. They currently have a GBX 1,050 price target on the stock.
Separately, Berenberg Bank lowered their price target on shares of Porvair from GBX 1,050 to GBX 1,000 and set a “buy” rating for the company in a report on Thursday. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, Porvair currently has a consensus rating of “Moderate Buy” and an average target price of GBX 1,025.
Porvair Price Performance
Shares of PRV stock opened at GBX 874 on Thursday. Porvair has a 1 year low of GBX 678.82 and a 1 year high of GBX 938. The company has a current ratio of 1.94, a quick ratio of 1.22 and a debt-to-equity ratio of 14.49. The firm’s 50 day moving average is GBX 871.03 and its 200-day moving average is GBX 818.73. The firm has a market capitalization of £403.83 million, a price-to-earnings ratio of 21.63 and a beta of 0.52.
About Porvair
Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications. The Laboratory segment is involved in the design and manufacture of instruments and consumables for use in environmental and bioscience laboratories with a focus on water analysis instruments, diagnostics, and sample preparation equipment.
Further Reading
- Five stocks we like better than Porvair
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.
